FIELD: medicine.
SUBSTANCE: estimation of clinical effectiveness of neoadjuvant chemotherapy of bladder cancer is ensured by urine sampling from the bladder filled for 3 hours to determine the urine UBC marker level at the primary diagnosis stage and 1 month after preoperative chemotherapy. If observing the UBC level decreasing by 30% and more from the initial value, a partial regress of tumour is detected, while the UBC level reduced or increased to 29 % shows the stabilisation process, and the UBC level increasing by 30 % and more from the initial value enables to detect progression of the tumour process.
EFFECT: use of the method ensures more efficient estimation of neoadjuvant chemotherapy of bladder cancer.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT CHEMICAL THERAPY OF URINARY BLADDER CANCER | 2009 |
|
RU2430374C2 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF MUSCULO-INVASIVE BLADDER CANCER FOLLOWING COMBINATION THERAPY | 2012 |
|
RU2538632C2 |
| METHOD OF COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER OF II AND III STAGE | 2011 |
|
RU2455986C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF CHEMOTHERAPY IN BLADDER CANCER ACCORDING TO MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2800817C1 |
| METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
| METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
| METHOD OF COMBINATION THERAPY APPLIED FOR LOCALLY ADVANCED CERVICAL CARCINOMA TYPES | 2006 |
|
RU2325199C2 |
| METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
| METHOD OF OPERABLE BREAST CANCER MEDICAL TREATMENT | 2006 |
|
RU2325914C2 |
| METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMICAL THERAPY IN PATIENTS WITH RESECTABLE BASAL-LIKE TRIPLE-NEGATIVE BREAST CANCER | 2013 |
|
RU2538638C1 |
